Director at Sherwin-Williams (NYSE: SHW) awarded 558 RSUs

Rhea-AI Filing Summary

Gamgort Robert James reported acquisition or exercise transactions in this Form 4 filing.

Sherwin-Williams director Robert James Gamgort reported receiving a grant of 558 restricted stock units (RSUs) of Common Stock on February 17, 2026 at a reported price of $0 per share under the 2025 Equity and Incentive Compensation Plan. Each RSU represents one share of Sherwin-Williams common stock and will vest in three substantially equal annual installments starting on February 16, 2027. After this grant, Gamgort beneficially owns 1,075 RSUs directly, and separately holds 380.04 deferred stock units indirectly through the 2005 Director Deferred Fee Plan, including units accumulated via dividend reinvestment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gamgort Robert James

(Last) (First) (Middle)

1 SHERWIN WAY

(Street)

CLEVELAND OH 44113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHERWIN WILLIAMS CO [ SHW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		A		558(1)	A	$0	1,075(2)	D
Common Stock(3)								380.04(4)	I	Deferred Fee Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units ("RSUs"), pursuant to the terms of an RSU agreement under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock. The RSUs vest annually in three substantially equal installments commencing February 16, 2027.

2. These securities consist of 1,075 RSUs.

3. No transaction is being reported on this line. Reported on a previously filed Form 4.

4. These securities consist of deferred stock units, held pursuant to the 2005 Director Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Remarks:

	Stephen J. Perisutti, Attorney-in-fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did SHW director Robert James Gamgort report?

Robert James Gamgort reported an acquisition of 558 restricted stock units of Sherwin-Williams Common Stock. The grant was recorded on February 17, 2026 as an award under the 2025 Equity and Incentive Compensation Plan at a reported price of $0 per share.

How many Sherwin-Williams RSUs does Robert James Gamgort now hold?

Following the reported grant, Robert James Gamgort beneficially owns 1,075 restricted stock units of Sherwin-Williams Common Stock directly. These RSUs are tied to the company’s 2025 Equity and Incentive Compensation Plan and are scheduled to vest over three annual installments beginning February 16, 2027.

When do Robert James Gamgort’s new Sherwin-Williams RSUs start vesting?

The newly granted Sherwin-Williams RSUs to Robert James Gamgort begin vesting on February 16, 2027. They vest annually in three substantially equal installments, meaning the award is spread over three years under the terms of the 2025 Equity and Incentive Compensation Plan.

What is the nature of the indirect Sherwin-Williams holdings reported by Gamgort?

In addition to directly held RSUs, Gamgort reported 380.04 deferred stock units held indirectly under the 2005 Director Deferred Fee Plan. These deferred units include amounts accumulated through the plan’s dividend reinvestment feature, reflecting stock-based fees deferred rather than taken in cash.

Was cash paid for the Sherwin-Williams RSU grant to director Gamgort?

The RSU grant to director Robert James Gamgort was reported at a transaction price of $0 per share. This indicates the award was granted as equity compensation under the 2025 Equity and Incentive Compensation Plan rather than purchased in an open-market cash transaction.

Does the Form 4 show any Sherwin-Williams stock sales by Robert James Gamgort?

The Form 4 reports a grant of 558 RSUs to Robert James Gamgort and updated holdings, but it does not show any sale transaction. One common stock line is described as having no new transaction, referencing a previously filed Form 4 for that position.